These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 23851493)

  • 21. Immunosurveillance of pancreatic adenocarcinoma: insights from genetically engineered mouse models of cancer.
    Clark CE; Beatty GL; Vonderheide RH
    Cancer Lett; 2009 Jun; 279(1):1-7. PubMed ID: 19013709
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of 2-arachidonoylglycerol in the regulation of the tumor-immune microenvironment in murine models of pancreatic cancer.
    Qiu C; Yang L; Wang B; Cui L; Li C; Zhuo Y; Zhang L; Zhang S; Zhang Q; Wang X
    Biomed Pharmacother; 2019 Jul; 115():108952. PubMed ID: 31078044
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Perineural Invasion Reprograms the Immune Microenvironment through Cholinergic Signaling in Pancreatic Ductal Adenocarcinoma.
    Yang MW; Tao LY; Jiang YS; Yang JY; Huo YM; Liu DJ; Li J; Fu XL; He R; Lin C; Liu W; Zhang JF; Hua R; Li Q; Jiang SH; Hu LP; Tian GA; Zhang XX; Niu N; Lu P; Shi J; Xiao GG; Wang LW; Xue J; Zhang ZG; Sun YW
    Cancer Res; 2020 May; 80(10):1991-2003. PubMed ID: 32098780
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The reciprocal regulation between host tissue and immune cells in pancreatic ductal adenocarcinoma: new insights and therapeutic implications.
    Liu X; Xu J; Zhang B; Liu J; Liang C; Meng Q; Hua J; Yu X; Shi S
    Mol Cancer; 2019 Dec; 18(1):184. PubMed ID: 31831007
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Advances in inducing adaptive immunity using cell-based cancer vaccines: Clinical applications in pancreatic cancer.
    Kajihara M; Takakura K; Kanai T; Ito Z; Matsumoto Y; Shimodaira S; Okamoto M; Ohkusa T; Koido S
    World J Gastroenterol; 2016 May; 22(18):4446-58. PubMed ID: 27182156
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dissecting the Stromal Signaling and Regulation of Myeloid Cells and Memory Effector T Cells in Pancreatic Cancer.
    Blair AB; Kim VM; Muth ST; Saung MT; Lokker N; Blouw B; Armstrong TD; Jaffee EM; Tsujikawa T; Coussens LM; He J; Burkhart RA; Wolfgang CL; Zheng L
    Clin Cancer Res; 2019 Sep; 25(17):5351-5363. PubMed ID: 31186314
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting both tumour-associated CXCR2
    Nywening TM; Belt BA; Cullinan DR; Panni RZ; Han BJ; Sanford DE; Jacobs RC; Ye J; Patel AA; Gillanders WE; Fields RC; DeNardo DG; Hawkins WG; Goedegebuure P; Linehan DC
    Gut; 2018 Jun; 67(6):1112-1123. PubMed ID: 29196437
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Topographical Distribution and Spatial Interactions of Innate and Semi-Innate Immune Cells in Pancreatic and Other Periampullary Adenocarcinoma.
    Lundgren S; Micke P; Elebro J; Heby M; Hrynchyk I; Nodin B; Leandersson K; Mezheyeuski A; Jirström K
    Front Immunol; 2020; 11():558169. PubMed ID: 33013928
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Composition, Spatial Characteristics, and Prognostic Significance of Myeloid Cell Infiltration in Pancreatic Cancer.
    Väyrynen SA; Zhang J; Yuan C; Väyrynen JP; Dias Costa A; Williams H; Morales-Oyarvide V; Lau MC; Rubinson DA; Dunne RF; Kozak MM; Wang W; Agostini-Vulaj D; Drage MG; Brais L; Reilly E; Rahma O; Clancy T; Wang J; Linehan DC; Aguirre AJ; Fuchs CS; Coussens LM; Chang DT; Koong AC; Hezel AF; Ogino S; Nowak JA; Wolpin BM
    Clin Cancer Res; 2021 Feb; 27(4):1069-1081. PubMed ID: 33262135
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Complex role for the immune system in initiation and progression of pancreatic cancer.
    Inman KS; Francis AA; Murray NR
    World J Gastroenterol; 2014 Aug; 20(32):11160-81. PubMed ID: 25170202
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dendritic Cell Paucity Leads to Dysfunctional Immune Surveillance in Pancreatic Cancer.
    Hegde S; Krisnawan VE; Herzog BH; Zuo C; Breden MA; Knolhoff BL; Hogg GD; Tang JP; Baer JM; Mpoy C; Lee KB; Alexander KA; Rogers BE; Murphy KM; Hawkins WG; Fields RC; DeSelm CJ; Schwarz JK; DeNardo DG
    Cancer Cell; 2020 Mar; 37(3):289-307.e9. PubMed ID: 32183949
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of FOXP3+ regulatory T cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesions.
    Hiraoka N; Onozato K; Kosuge T; Hirohashi S
    Clin Cancer Res; 2006 Sep; 12(18):5423-34. PubMed ID: 17000676
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inflammation and Pancreatic Cancer: Focus on Metabolism, Cytokines, and Immunity.
    Padoan A; Plebani M; Basso D
    Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30764482
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Infiltrated B cells promote pancreatic ductal adenocarcinoma].
    Seiller C; Dubois B
    Med Sci (Paris); 2017 Oct; 33(10):859-862. PubMed ID: 28994380
    [No Abstract]   [Full Text] [Related]  

  • 35. The Role of Stromal Components in Pancreatic Cancer Progression.
    Xu M; Zhou BP; Tao M; Liu J; Li W
    Anticancer Agents Med Chem; 2016; 16(9):1117-24. PubMed ID: 27039918
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor-derived granulocyte-macrophage colony-stimulating factor regulates myeloid inflammation and T cell immunity in pancreatic cancer.
    Bayne LJ; Beatty GL; Jhala N; Clark CE; Rhim AD; Stanger BZ; Vonderheide RH
    Cancer Cell; 2012 Jun; 21(6):822-35. PubMed ID: 22698406
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic significance of mast cell count following curative resection for pancreatic ductal adenocarcinoma.
    Cai SW; Yang SZ; Gao J; Pan K; Chen JY; Wang YL; Wei LX; Dong JH
    Surgery; 2011 Apr; 149(4):576-84. PubMed ID: 21167541
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discrepancies in the Tumor Microenvironment of Spontaneous and Orthotopic Murine Models of Pancreatic Cancer Uncover a New Immunostimulatory Phenotype for B Cells.
    Spear S; Candido JB; McDermott JR; Ghirelli C; Maniati E; Beers SA; Balkwill FR; Kocher HM; Capasso M
    Front Immunol; 2019; 10():542. PubMed ID: 30972056
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Paradoxical Web of Pancreatic Cancer Tumor Microenvironment.
    Lafaro KJ; Melstrom LG
    Am J Pathol; 2019 Jan; 189(1):44-57. PubMed ID: 30558722
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor microenvironment and progression of pancreatic cancer.
    Erkan M; Reiser-Erkan C; Michalski CW; Kleeff J
    Exp Oncol; 2010 Sep; 32(3):128-31. PubMed ID: 21403605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.